Otrivin Unpreserved Nasal Spray

Otrivin is a well-known brand of nasal decongestant originally developed in Switzerland by the pharmaceutical company Novartis (Ciba-Geigy). Today, it is part of the portfolio of Haleon, a global leader in consumer health that was formed through a joint venture between GSK and Pfizer before being spun off as an independent company.

While the brand has its roots in Switzerland, manufacturing occurs in various locations globally to serve different markets. The version shown, labeled for the Danish market as "Ukonserveret" (unpreserved), is distributed locally by Haleon Denmark ApS. The active ingredient is xylometazoline hydrochloride, which works to reduce swelling in the nasal passages.